<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">The protective effect of humoral immunity against human coronaviruses is still debated, and some evidence even points out a potential Antibody Dependent Enhancement (ADE) triggered by secondary infections featuring the severe/critical forms of COVID-19, as with other viral diseases such as Dengue, SARS-CoV-1, MERS-CoV and the West Nile Virus. (
 <xref rid="bib17" ref-type="bibr">Cegolon et al. 2020</xref>). Given the potential of reversed and untoward consequences following relaxation of the above IPC measures, especially during cold months, and in absence of a specific registered treatment or vaccine against SARS-CoV-2, there is a clear and urgent need to find alternative solutions to prevent and control the replication of the virus and the spread of COVID-19 among humans (
 <xref rid="bib82" ref-type="bibr">Yu et al., 2020</xref>).
</p>
